A network-based analysis of systemic inflammation in humans SE Calvano, W Xiao, DR Richards, RM Felciano, HV Baker, RJ Cho, ... Nature 437 (7061), 1032-1037, 2005 | 1655 | 2005 |
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1210 | 1995 |
Cytokines and the brain: implications for clinical psychiatry Z Kronfol, DG Remick American Journal of Psychiatry 157 (5), 683-694, 2000 | 1125 | 2000 |
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. LM Colletti, DG Remick, GD Burtch, SL Kunkel, RM Strieter, DA Campbell The Journal of clinical investigation 85 (6), 1936-1943, 1990 | 1048 | 1990 |
Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β RM Strieter, SL Kunkel, HJ Showell, DG Remick, SH Phan, PA Ward, ... Science 243 (4897), 1467-1469, 1989 | 1035 | 1989 |
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. SL Kunkel, M Spengler, MA May, R Spengler, J Larrick, D Remick Journal of Biological Chemistry 263 (11), 5380-5384, 1988 | 835 | 1988 |
The pathogenesis of sepsis DJ Stearns-Kurosawa, MF Osuchowski, C Valentine, S Kurosawa, ... Annual review of pathology: mechanisms of disease 6, 19-48, 2011 | 778 | 2011 |
Pathophysiology of sepsis DG Remick The American journal of pathology 170 (5), 1435-1444, 2007 | 766 | 2007 |
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline RM Strieter, DG Remick, PA Ward, RN Spengler, JP Lynch Iii, J Larrick, ... Biochemical and biophysical research communications 155 (3), 1230-1236, 1988 | 747 | 1988 |
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality MF Osuchowski, K Welch, J Siddiqui, DG Remick The Journal of Immunology 177 (3), 1967-1974, 2006 | 741 | 2006 |
Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture DG Remick, DE Newcomb, GL Bolgos, DR Call Shock 13 (2), 110-116, 2000 | 674 | 2000 |
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding KN Iskander, MF Osuchowski, DJ Stearns-Kurosawa, S Kurosawa, ... Physiological reviews 93 (3), 1247-1288, 2013 | 540 | 2013 |
Acute inflammatory response to endotoxin in mice and humans S Copeland, HS Warren, SF Lowry, SE Calvano, D Remick Clinical and Vaccine Immunology 12 (1), 60-67, 2005 | 528 | 2005 |
Regulation of interleukin 8 gene expression by oxidant stress. LE DeForge, AM Preston, E Takeuchi, J Kenney, LA Boxer, DG Remick Journal of Biological Chemistry 268 (34), 25568-25576, 1993 | 512 | 1993 |
Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days DG Remick, GR Bolgos, J Siddiqui, J Shin, JA Nemzek Shock 17 (6), 463-467, 2002 | 505 | 2002 |
Acute pancreatitis: models, markers, and mediators J Granger, D Remick Shock 24, 45-51, 2005 | 481 | 2005 |
Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. RN Spengler, RM Allen, DG Remick, RM Strieter, SL Kunkel Journal of immunology (Baltimore, Md.: 1950) 145 (5), 1430-1434, 1990 | 469 | 1990 |
Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. MK Eskandari, G Bolgos, C Miller, DT Nguyen, LE DeForge, DG Remick Journal of immunology (Baltimore, Md.: 1950) 148 (9), 2724-2730, 1992 | 436 | 1992 |
IL-8 in septic shock, endotoxemia, and after IL-1 administration. KJ Van Zee, LE DeForge, E Fischer, MA Marano, JS Kenney, DG Remick, ... Journal of immunology (Baltimore, Md.: 1950) 146 (10), 3478-3482, 1991 | 429 | 1991 |
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. E Fischer, MA Marano, KJ Van Zee, CS Rock, AS Hawes, WA Thompson, ... The Journal of clinical investigation 89 (5), 1551-1557, 1992 | 394 | 1992 |